chr10-87863959-G-A

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 1P and 18B. PP2BP4_ModerateBP6_Very_StrongBA1

The NM_001304717.5(PTEN):​c.10G>A​(p.Gly4Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.143 in 381,510 control chromosomes in the GnomAD database, including 4,826 homozygotes. In-silico tool predicts a benign outcome for this variant. 4/5 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). The gene PTEN is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.13 ( 1493 hom., cov: 31)
Exomes 𝑓: 0.15 ( 3333 hom. )

Consequence

PTEN
NM_001304717.5 missense

Scores

1
1

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:11

Conservation

PhyloP100: 2.14

Publications

24 publications found
Variant links:
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
PTEN Gene-Disease associations (from GenCC):
  • Cowden syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • PTEN hamartoma tumor syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • macrocephaly-autism syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
  • renal cell carcinoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • leiomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • activated PI3K-delta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bannayan-Riley-Ruvalcaba syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lhermitte-Duclos disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Proteus-like syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • glioma susceptibility 2
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PP2
Missense variant in the PTEN gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 209 curated pathogenic missense variants (we use a threshold of 10). The gene has 22 curated benign missense variants. Gene score misZ: 3.4883 (above the threshold of 3.09). Trascript score misZ: 4.001 (above the threshold of 3.09). GenCC associations: The gene is linked to Cowden syndrome 1, PTEN hamartoma tumor syndrome, macrocephaly-autism syndrome, glioma susceptibility 2, activated PI3K-delta syndrome, Lhermitte-Duclos disease, Bannayan-Riley-Ruvalcaba syndrome, leiomyosarcoma, Cowden disease, renal cell carcinoma, Proteus-like syndrome.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 10-87863959-G-A is Benign according to our data. Variant chr10-87863959-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 810888.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.335 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001304717.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTEN
NM_000314.8
MANE Select
c.-511G>A
5_prime_UTR
Exon 1 of 9NP_000305.3
PTEN
NM_001304717.5
c.10G>Ap.Gly4Arg
missense
Exon 1 of 10NP_001291646.4
PTEN
NM_001304718.2
c.-1216G>A
5_prime_UTR
Exon 1 of 9NP_001291647.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTEN
ENST00000371953.8
TSL:1 MANE Select
c.-511G>A
5_prime_UTR
Exon 1 of 9ENSP00000361021.3P60484-1
PTEN
ENST00000693560.1
c.10G>Ap.Gly4Arg
missense
Exon 1 of 10ENSP00000509861.1A0A8I5KSF9
PTEN
ENST00000700029.2
c.-511G>A
5_prime_UTR
Exon 1 of 10ENSP00000514759.2A0A8V8TPK6

Frequencies

GnomAD3 genomes
AF:
0.126
AC:
18970
AN:
150292
Hom.:
1491
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0614
Gnomad AMI
AF:
0.0592
Gnomad AMR
AF:
0.193
Gnomad ASJ
AF:
0.121
Gnomad EAS
AF:
0.349
Gnomad SAS
AF:
0.124
Gnomad FIN
AF:
0.109
Gnomad MID
AF:
0.134
Gnomad NFE
AF:
0.138
Gnomad OTH
AF:
0.139
GnomAD4 exome
AF:
0.154
AC:
35529
AN:
231108
Hom.:
3333
Cov.:
0
AF XY:
0.152
AC XY:
18136
AN XY:
119532
show subpopulations
African (AFR)
AF:
0.0618
AC:
389
AN:
6294
American (AMR)
AF:
0.213
AC:
1402
AN:
6590
Ashkenazi Jewish (ASJ)
AF:
0.112
AC:
911
AN:
8120
East Asian (EAS)
AF:
0.349
AC:
7648
AN:
21894
South Asian (SAS)
AF:
0.130
AC:
417
AN:
3202
European-Finnish (FIN)
AF:
0.113
AC:
2260
AN:
19954
Middle Eastern (MID)
AF:
0.0794
AC:
93
AN:
1172
European-Non Finnish (NFE)
AF:
0.135
AC:
20128
AN:
149084
Other (OTH)
AF:
0.154
AC:
2281
AN:
14798
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
1562
3124
4687
6249
7811
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.126
AC:
18981
AN:
150402
Hom.:
1493
Cov.:
31
AF XY:
0.127
AC XY:
9318
AN XY:
73528
show subpopulations
African (AFR)
AF:
0.0615
AC:
2524
AN:
41012
American (AMR)
AF:
0.193
AC:
2935
AN:
15172
Ashkenazi Jewish (ASJ)
AF:
0.121
AC:
416
AN:
3450
East Asian (EAS)
AF:
0.349
AC:
1745
AN:
5004
South Asian (SAS)
AF:
0.124
AC:
593
AN:
4772
European-Finnish (FIN)
AF:
0.109
AC:
1119
AN:
10308
Middle Eastern (MID)
AF:
0.127
AC:
36
AN:
284
European-Non Finnish (NFE)
AF:
0.138
AC:
9270
AN:
67398
Other (OTH)
AF:
0.138
AC:
290
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
803
1606
2408
3211
4014
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0599
Hom.:
63
Bravo
AF:
0.131
Asia WGS
AF:
0.212
AC:
730
AN:
3438

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
3
not provided (3)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Macrocephaly-autism syndrome;C2751642:Glioma susceptibility 2;C2931456:Familial prostate cancer;C3551915:Familial meningioma;CN072330:Cowden syndrome 1 (1)
1
-
-
Myeloproliferative neoplasm, unclassifiable (1)
-
-
1
PTEN hamartoma tumor syndrome (1)
-
-
1
PTEN-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
20
DANN
Uncertain
0.99
PhyloP100
2.1
PromoterAI
-0.10
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=279/21
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12573787; hg19: chr10-89623716; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.